Antifungal Host Defense Peptides

作者: Karl Lohner , Regina Leber

DOI: 10.1007/978-3-319-32949-9_2

关键词:

摘要: Fungi infect billions of people every year, yet their contribution to the global burden disease is largely unrecognized and repertoire antifungal agents rather limited. Thus, treatment life-threatening invasive fungal infections still based on drugs discovered several decades ago. In addition, recent data resistance emergence fungi emphasize urgent need for novel treatments. One alternative strategy host defense peptides. Among large number antimicrobial peptides, a group peptides show primarily activity by interfering with enzymes cell wall biosynthesis or specific membrane lipids such as ergosterol. Both are promising targets they absent in mammalian cells hence low toxicity can be expected. However, most exhibit broad spectrum including activity. These act level although structures vary largely, share positive net charge, which facilitates electrostatic interactions negatively charged target cell, an amphipathic structure, incorporation into turn disruption. Thereby, differing between mammals play central role concerning specificity efficacy these Hence, understanding molecular mechanism(s) action will aid design agents. Finally, some were shown synergistically conventional drugs, would further widen armory treat especially infections.

参考文章(189)
Reményi P, Kapás B, Lueff S, Réti M, Nagy Iz, Bátai A, Tremmel A, Goda, Kriván G, Masszi T, Sinkó J, Successful combined antifungal salvage therapy with liposomal amphothericin B and caspofungin for invasive Aspergillus flavus infection in a child following allogeneic bone marrow transplantation. Acta bio-medica : Atenei Parmensis. pp. 17- 21 ,(2006)
Helen W Boucher, Andreas H Groll, Christine C Chiou, Thomas J Walsh, Newer systemic antifungal agents : pharmacokinetics, safety and efficacy. Drugs. ,vol. 64, pp. 1997- 2020 ,(2004) , 10.2165/00003495-200464180-00001
H. Vanden Bossche, P. Marichal, G. Willemsens, D. Bellens, J. Gorrens, I. Roels, M.-C. Coene, L. Le Jeune, P. A. J. Janssen, Saperconazole: a selective inhibitor of the cytochrome P-450-dependent ergosterol synthesis in Candida albicans, Aspergillus fumigatus and Trichophyton mentagrophytes. Mycoses. ,vol. 33, pp. 335- 352 ,(1990) , 10.1111/MYC.1990.33.7-8.335
Eugene A. Rogozhin, Marina P. Slezina, Anna A. Slavokhotova, Ekaterina A. Istomina, Tatyana V. Korostyleva, Alexey N. Smirnov, Eugene V. Grishin, Tsezi A. Egorov, Tatyana I. Odintsova, A novel antifungal peptide from leaves of the weed Stellaria media L Biochimie. ,vol. 116, pp. 125- 132 ,(2015) , 10.1016/J.BIOCHI.2015.07.014
S P Franzot, A Casadevall, Pneumocandin L-743,872 enhances the activities of amphotericin B and fluconazole against Cryptococcus neoformans in vitro. Antimicrobial Agents and Chemotherapy. ,vol. 41, pp. 331- 336 ,(1997) , 10.1128/AAC.41.2.331
Philippe F. Devaux, Roger Morris, Transmembrane asymmetry and lateral domains in biological membranes. Traffic. ,vol. 5, pp. 241- 246 ,(2004) , 10.1111/J.1600-0854.2004.0170.X
F G Oppenheim, T Xu, F M McMillian, S M Levitz, R D Diamond, G D Offner, R F Troxler, Histatins, a novel family of histidine-rich proteins in human parotid secretion. Isolation, characterization, primary structure, and fungistatic effects on Candida albicans. Journal of Biological Chemistry. ,vol. 263, pp. 7472- 7477 ,(1988) , 10.1016/S0021-9258(18)68522-9
Drew Marquardt, Barbara Geier, Georg Pabst, Asymmetric lipid membranes: towards more realistic model systems. Membranes. ,vol. 5, pp. 180- 196 ,(2015) , 10.3390/MEMBRANES5020180
P Fehlbaum, P Bulet, L Michaut, M Lagueux, W F Broekaert, C Hetru, J A Hoffmann, Insect immunity. Septic injury of Drosophila induces the synthesis of a potent antifungal peptide with sequence homology to plant antifungal peptides. Journal of Biological Chemistry. ,vol. 269, pp. 33159- 33163 ,(1994) , 10.1016/S0021-9258(20)30111-3